{
  "cik": "0001754068",
  "name": "Kalaris Therapeutics, Inc.",
  "entityType": "operating",
  "sic": "2836",
  "sicDescription": "Biological Products, (No Diagnostic Substances)",
  "stateOfIncorporation": "DE",
  "stateOfIncorporationDescription": "DE",
  "fiscalYearEnd": "1231",
  "tickers": [
    "KLRS"
  ],
  "exchanges": [
    "Nasdaq"
  ],
  "ein": "831971007",
  "description": "",
  "website": "",
  "investorWebsite": "",
  "category": "<br>Emerging growth company",
  "phone": "650-249-2727",
  "flags": "",
  "formerNames": [
    {
      "name": "Allovir, Inc.",
      "from": "2019-05-22T04:00:00.000Z",
      "to": "2025-03-12T04:00:00.000Z"
    },
    {
      "name": "ViraCyte, Inc.",
      "from": "2018-10-02T04:00:00.000Z",
      "to": "2018-10-02T04:00:00.000Z"
    }
  ],
  "filings_count": 637,
  "download_timestamp": "2025-08-02 07:22:54 UTC"
}